A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Manufacturers are developing platform technologies for personalized CRISPR gene-editing therapies following the Baby KJ case.
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.
By Pietro Antonio Ciclese, Senior Technical Marketing Engineer, Ambarella The workloads that generate the most commercial ...
MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, has announced a groundbreaking achievement of great theoretical and engineering significance: its ...
On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...
Trapped ion quantum computing noise hit a 30-year wall until ETH Zurich researchers built a Penning-trap scanner using a ...
A fileless malware framework has been abusing Google's Blogspot platform to deliver the PureLog Stealer entirely in memory, letting attackers steal credentials while leaving few traces on disk.
The Korean government-funded project will build a brain and AI-controlled full-body exoskeleton for quadriplegic patients.
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results